Post

How to get URL link on X (Twitter) App

On the Twitter thread, click on or icon on the bottom
Click again on or Share Via icon
Click on Copy Link to Tweet
Paste it above and click "Unroll Thread"!
More info at Twitter Help

🇩🇰 The Danish Dude 🇬🇱

@FlemmingBruce

May 25, 2023 • 8 tweets • 3 min read • Read on X

Scrolly

@DCarnival46

$NWBO @DCarnival46

#CancerMoonshot today will not only be about glioblastoma, but about the horrible DIPG (diffuse intrinsic pontine glioma) occuring in children and young adults.

You know who got their PIP plan approved last year by the MHRA in the UK?

You know who ANNOUNCED a new center of cancer excellence in Sutton in the UK two months ago, 130 miles from Sawston, focusing on DIPG?

You know who donated 2.5 million pounds to the center and that Hugh Adams works for them and have helped NWBO meeting british politicians and he wrote the "Pathway to a Cure" report, where politicians urges MHRA and NICE to get DCVax-L to patients?

SAME DAY MHRA announced this

"This new funding will accelerate the delivery of cutting-edge treatments like cancer vaccines"

One week later the MHRA announced this.

The new Quarterly SEC filing says

"We plan to work on preparations for Phase II trials of DCVax-Direct as resources permit."

You know NWBO already had planned DCVax-Direct trials in 2019 targeting DIPG?

nwbio.com/wp-content/upl…

Just saying.

@DCarnival46

@DCarnival46 @threadreaderapp unroll

• • •

Missing some Tweet in this thread? You can try to force a refresh

This Thread may be Removed Anytime!

Twitter may remove this content at anytime! Save it as PDF for later use!

More from @FlemmingBruce

🇩🇰 The Danish Dude 🇬🇱

@FlemmingBruce

Apr 24

$NWBO

1/7

If $NWBO’s DCVax-L is approved for both Grade 3 & 4 gliomas, covering newly diagnosed and recurrent GBM, it’s a major leap forward — not just a drug approval, but platform validation.

Here’s what it would mean:

2/7

Such a broad label would:

• Expand the patient population
• Boost valuation
• Open doors to pan-solid tumor use
• Strengthen NWBO’s case for NICE + EU filings

It flips the “niche drug” narrative on its head.

3/7

Grade 3 gliomas (like anaplastic astrocytomas) share molecular traits with GBM.

MHRA could approve based on DCVax’s mechanism + safety, even without separate trials.

Especially under ILAP, MHRA is open to platform logic.

Read 7 tweets

🇩🇰 The Danish Dude 🇬🇱

@FlemmingBruce

Apr 15

1/

$NWBO trading has been suspended on Börse Stuttgart since April 9.

No trades. No fix. No public explanation.

While Stuttgart is a secondary exchange, this extended halt may carry broader implications.

Here’s what we know.

Thanks to @smith348572 for due diligence 🙏🏻

2/

Börse Berlin — another German exchange — publicly warns that OTC stocks can be subject to fraudulent trading practices that occur simultaneously in the U.S. and Germany.

This highlights cross-market vulnerabilities, particularly in thinly traded securities.

3/

Stuttgart is a low-volume venue for NWBO (often only a few thousand shares per week).

This illiquidity can, in theory, make it easier for actors to influence quote pricing or create artificial order flow, potentially impacting broader market signals.

Read 16 tweets

🇩🇰 The Danish Dude 🇬🇱

@FlemmingBruce

Apr 9

$NWBO

NICE updated status on NWBO collaboration.

ChatGPT, Grok & Gemini say:

"NICE’s active appraisal of DCVax-L signals MHRA approval is imminent or already granted — unlocking the path to NHS funding, UK rollout, & real revenue.
👉 Huge validation for $NWBO & patients."

👇

ChatGPT:

💥 NWBO milestone:

NICE (UK) is appraising DCVax-L for glioblastoma (GID-TA10143).

This strongly signals MHRA approval is imminent—or already granted (but not yet announced).

It’s about routine NHS use. Here’s why:

🔎 NICE’s Role:

NICE evaluates whether new treatments should be funded by the NHS in England & Wales.

➡️ Appraisals like this only start after MHRA approval — or when it’s expected very soon.

Read 14 tweets

🇩🇰 The Danish Dude 🇬🇱

@FlemmingBruce

Mar 28

$NWBO

Read 8 tweets

🇩🇰 The Danish Dude 🇬🇱

@FlemmingBruce

Mar 28

$NWBO

Spoofing has continued until the ruling. Probably also naked shorting.

Would market makers be able to continue and hope this will not be revealed during discovery or would they be better of to stop?

Read 5 tweets

🇩🇰 The Danish Dude 🇬🇱

@FlemmingBruce

Mar 26

$NWBO

I have made several AI's concurrently look into all SEC filings, PR's, ASMs and all criticism today on Investorshub into this thesis, and correlating their answers between them:

Was Flaskworks EDEN
included in the
MAA for DCVax-L?

In short?